Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States
Past Federal grant forecast Posted
- Opportunity number
- RFA-IP-21-005
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications expected due
- Award size
- $1,440,000 to $2,150,000
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- City/Township Governments
- Special District Governments
- Higher Education Inst. (Public)
- Public or Indian Housing Auth.
- Non-501(c)(3) Nonprofits
- State Governments
- Tribal Governments (Federally Recognized)
- Independent School Districts
- 501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Private)
- County Governments
Opportunity details come from Grants.gov. Updated .
Forecast synopsis
Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza vaccines, and for novel vaccines such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to: a) support a network of US institutions that can obtain reliable vaccination information for a population, or cohort of individuals; b) provide accurate estimates of the effectiveness of vaccines against respiratory viruses including influenza, SARS-CoV-2 and other respiratory viruses that may emerge; and c) prevent medically attended influenza-associated illness in the population for whom influenza vaccination is recommended.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity